Nursing Regulatory Boards Efforts to Provide Guidance to Nurses About Mitigating Prescription Medication Abuse/Diversion

Size: px
Start display at page:

Download "Nursing Regulatory Boards Efforts to Provide Guidance to Nurses About Mitigating Prescription Medication Abuse/Diversion"

Transcription

1 Nursing Regulatory Boards Efforts to Provide Guidance to Nurses About Mitigating Prescription Medication Abuse/Diversion Cathy Carlson, PhD, APN, FNP-BC Aaron Gilson, MS, MSSW, PhD Authors Conflicts of Interest: C. Carlson, No Conflict of Interest A. Gilson, No Conflict of Interest Participants should: Understand the current epidemiological evidence about the non-medical use of prescription opioid medications in the U.S., as well as important considerations when interpreting this information, including the role of diversion Understand the methodology used to evaluate all states nursing board websites to identify content related to prescription opioid medication abuse and diversion Identify the variety of ways that state nursing board websites are used to inform licensees about mitigating prescription opioid medication abuse and diversion Identify the different content available through state nursing board websites about reducing prescription opioid medication abuse and diversion Define quality indicators of state nursing boards efforts to reduce prescription opioid medication abuse and diversion Recognize additional approaches that state nursing boards could use to encourage licensees to incorporate in their practice to reduce prescription opioid medication abuse and diversion 1

2 Deaths involving prescription opioid analgesics outnumber deaths from heroin and cocaine combined 20,000 Overdose Deaths Involving Opioid Analgesics, Cocaine, & Heroin: U. S ,000 16,000 14,000 12,000 10,000 8,000 6,000 4,000 2, Opioid Analgesics** Cocaine Heroin National Institute on Drug Abuse. (December, 2015). Overdose death rates. Retrieved from Sources of drugs for non-medical users, Percent % Friend or relative for free Friend or relative for cost Friend or relative wo knowledge Drug dealer or stranger Other illicit sources Prescription Substance Abuse and Mental Health Services Administration. (September, 2014). Summary of National Findings. Retrieved from Prescription medication Prescribed medication Essential to determine whether valid prescription was involved 2

3 Senate Testimony: Over the past several years hundreds of millions of dosage units of controlled substanceswere diverted into the illicit marketplace across the United States. (July, 2012, p. 5) Factors to Consider Diversion (i.e., no prescription found) Doctor-shopping (i.e., diversion) Motivations?? Non-medical routes of administration Co-morbidities (e.g., substance use history) Poly-pharmacy Previous overdose episodes Little clinical information Not a linear effect Not causal Legitimate Patients? Methadone Analgesics with No Abuse Potential Practitioner Education Treatment Benefit/Risk Evaluations ED Guidelines Safeguarding Prescription Pads Drug Formularies 3

4 2-week evaluation period (June 1- June 14) CC & AG separately reviewed each state s website Content created on or after January 1, 2013 Reviewed websites for territories lack of websites or information excluded them from final analysis Excluded content: Policy/laws Nurse impairment/nurse abuse & diversion Met on June 14 to coordinate findings AG created categories for content and methods to relay information Inter-rater reliability = (Fair agreement) CUMULATIVELY identified at least most of the recent information No content = 15 states (29%) Some websites had older content, and were not tallied Some resources not directly accessible via nursing board website CT, MI 4

5 Availability of Information Single page CO, MN, NH, OR, RI, TX, WY Resources only available through APN section Some under Pain Management Most states had information strewn throughout site Mechanisms for Relaying Information DC Slide Show (3 states) No Slide Show (48 states) 5

6 Video (3 states) No Video (48 states) 6

7 News (11 states) No News (40 states) Practice Notices (14 states) No Practice Notices (37 states) 7

8 DC Newsletter (16 states) No Newsletter (35 states) 8

9 DC Links (20 states) No Links (31 states) Topics Offered PDMP information (20 states) PDMP registration (2 states) PDMP information and registration (5 states) No content (24 states) 9

10 DC Substance Abuse (3 states) Controlled Substances Prescribing (1 state) PDMP (1 state) REMS (1 state) Substance Abuse & CS Rx (1 state) Substance Abuse & REMS (2 states) No content (42 states) DC Diversion (4 states) Aberrant Behaviors/Drug Seeking (3 states) Drug Disposal/Wasting (3 states) Take Back (2 states) Prescription Fraud Reporting (1 state) Securing Medications (1 state) No content (37 states) Drug Misuse & Abuse/Prescription Safety (14 states) No Content (37 states) 10

11 DC Preventing Adverse Events/Harm Reduction/Overdose (9 states) No Content (42 states) Naloxone Content (7 states) No Content (44 states) DC Any Content (36 states) No Content (15 states) 11

12 Quality Indicators for State Boards of Nursing Websites Definitions: An inherent or distinguishing characteristic; a property or attribute A personal trait, especially a character trait Essential character; nature Superiority of kind Degree or grade of excellence ISO 9000: Degree to which a set of inherent characteristics fulfills requirements A perceptual, conditional, and somewhat subjective attribute understood differently by different people Verifiable measures stated in either quantitative or qualitative terms that: Capture performance in terms of how something is being done relative to a standard or target Allow and encourage comparison Support the goals and objectives of the organization Performance metrics (i.e., Indicators) often represent how far a metric is above or below a specified target 12

13 The link to the (PDMP) in each state needs to be readily accessible by nurses and especially advanced practice registered nurses (APRNs) E-newsletters should be an option for nursing professionals from their SBN Requiring course regarding opioid prescribing, abuse and/or diversion Facebook posts provides licensees with useful information 13

14 Separate page/link for APRNs Separate page/link for pain management Separate page/link for public/professional Header Navigation Links Local Navigation Links Main Content Page Right Column Footer Exemplars 14

15 All websites should have content for licensees related to addressing prescription medication abuse/diversion Links to external resources NCSBN could encourage such content Content should be easily searchable (e.g., 1 page) Other topics could be addressed Prescription form security/tamper-resistant forms Prescription series E-prescribing Coordinated care/integrative care PCSS-Ois a collaborative effort led by American Academy of Addiction Psychiatry (AAAP) in partnership with: Addiction Technology Transfer Center (ATTC), American Academy of Neurology (AAN), American Academy of Pain Medicine (AAPM), American Academy of Pediatrics (AAP), American College of Physicians (ACP), American Dental Association (ADA), American Medical Association (AMA), American Osteopathic Academy of Addiction Medicine (AOAAM), American Psychiatric Association (APA), American Society for Pain Management Nursing (ASPMN), International Nurses Society on Addictions (IntNSA), and Southeast Consortium for Substance Abuse Training (SECSAT). For more information visit: For questions pcss-o@aaap.org Funding for this initiative was made possible (in part) by Providers Clinical Twitter: System for Opioid Therapies (grant no. 5H79TI025595) from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government. 15

Addiction Prediction: Errors from the bedside hurt patients with pain. Objectives. CDC guideline for prescribing OPIOIDS for Chronic Pain

Addiction Prediction: Errors from the bedside hurt patients with pain. Objectives. CDC guideline for prescribing OPIOIDS for Chronic Pain Addiction Prediction: Errors from the bedside hurt patients with pain Renee C.B. Manworren, PhD, APRN, BC, PCNS-BC, AP-PMN, FAAN Director of Nursing Research and Professional Practice Posy and Fred Love

More information

Pain Care & Prescription Drug Abuse: Current Topics, Legislation & Policy. Disclosure. Preview

Pain Care & Prescription Drug Abuse: Current Topics, Legislation & Policy. Disclosure. Preview Providers Clinical Support System for Opioid Therapies (PCSS-O) Webinar March 7, 2017 Pain Care & Prescription Drug Abuse: Current Topics, Legislation & Policy Wade Delk, Government Affairs Director, ASPMN

More information

Course Overview Management of Chronic Pain: A Core Curriculum for Primary Care Providers

Course Overview Management of Chronic Pain: A Core Curriculum for Primary Care Providers Course Overview Management of Chronic Pain: A Core Curriculum for Primary Care Providers Sponsored by PCSS-O American Academy of Addiction Psychiatry Roger Chou, MD 1 About PCSS-O PCSS-O is a national

More information

STOPPING OPIOIDS. William Morrone, DO MS, FACOFP DABAM DAAPM Deputy Chief Medical Examiner & AOAAM June 24, 2015 Noon ET

STOPPING OPIOIDS. William Morrone, DO MS, FACOFP DABAM DAAPM Deputy Chief Medical Examiner & AOAAM June 24, 2015 Noon ET STOPPING OPIOIDS William Morrone, DO MS, FACOFP DABAM DAAPM Deputy Chief Medical Examiner & AOAAM June 24, 2015 Noon ET 1 William Morrone DO, Disclosures William Morrone, DO has presented numerous programs

More information

PCSS Projects. Kathryn L. Cates-Wessel Executive Director, AAAP PCSS-MAT and PCSS-O PI and Project Director

PCSS Projects. Kathryn L. Cates-Wessel Executive Director, AAAP PCSS-MAT and PCSS-O PI and Project Director PCSS Projects Kathryn L. Cates-Wessel Executive Director, AAAP PCSS-MAT and PCSS-O PI and Project Director 1 Educational Objectives At the conclusion of this activity participants should be able to: Describe

More information

Opioids for Pain Treatment in Persons with Opioid Use Disorder. Patricia Pade, MD Seddon R. Savage, MD, MS Melissa Weimer, DO, MCR

Opioids for Pain Treatment in Persons with Opioid Use Disorder. Patricia Pade, MD Seddon R. Savage, MD, MS Melissa Weimer, DO, MCR Opioids for Pain Treatment in Persons with Opioid Use Disorder Patricia Pade, MD Seddon R. Savage, MD, MS Melissa Weimer, DO, MCR 1 Educational Objectives At the conclusion of this activity participants

More information

Managing Pain in the Patient with Opioid Use Disorder: Inpatient Management. Melissa Weimer, DO, MCR Oregon Health & Science University

Managing Pain in the Patient with Opioid Use Disorder: Inpatient Management. Melissa Weimer, DO, MCR Oregon Health & Science University Managing Pain in the Patient with Opioid Use Disorder: Inpatient Management Melissa Weimer, DO, MCR Oregon Health & Science University 1 Educational Objectives At the conclusion of this activity participants

More information

2016 American Academy of Neurology

2016 American Academy of Neurology 2016 American Academy of Neurology PCSS-O is a collaborative effort led by American Academy of Addiction Psychiatry (AAAP) in partnership with: Addiction Technology Transfer Center (ATTC), American Academy

More information

Application of Advanced Practice Nurses Attitudes and Behaviors about Opioid Prescribing for Chronic Pain Survey

Application of Advanced Practice Nurses Attitudes and Behaviors about Opioid Prescribing for Chronic Pain Survey Application of Advanced Practice Nurses Attitudes and Behaviors about Opioid Prescribing for Chronic Pain Survey Pat Bruckenthal, PhD, APRN-BC, ANP Aaron Gilson, MS, MSSW, PhD Conflict of Interest Disclosure

More information

Disposal of Medicines, including Opioids with Your Patients

Disposal of Medicines, including Opioids with Your Patients American Dental Association - Webinar March 29, 2017 Discussing Safe Use, Storage and Disposal of Medicines, including Opioids with Your Patients Deborah Davidson, Senior Director, Member Relations & Special

More information

Rates of Opioid Misuse, Abuse, and Addiction in Chronic Pain. Kevin E. Vowles, PhD University of New Mexico

Rates of Opioid Misuse, Abuse, and Addiction in Chronic Pain. Kevin E. Vowles, PhD University of New Mexico Rates of Opioid Misuse, Abuse, and Addiction in Chronic Pain Kevin E. Vowles, PhD University of New Mexico 1 Kevin E. Vowles, Disclosures Consultant, Pfizer Independent Grants for Learning and Change,

More information

Disclosures. Target Audience 4/28/2015. The Road Less Traveled: Using Buprenorphine-Naloxone to Treat High-Risk Chronic Pain Patients

Disclosures. Target Audience 4/28/2015. The Road Less Traveled: Using Buprenorphine-Naloxone to Treat High-Risk Chronic Pain Patients The Road Less Traveled: Using Buprenorphine-Naloxone to Treat High-Risk Chronic Pain Patients Patrick Marshalek, MD Jenna Martino, MSN, FNP-C Audrey Royce, MSN, FNP-C Sarah Roy, MSN, RN, CCRN West Virginia

More information

Disclosures. Objectives. The Opioid Epidemic: Improving Opioid Safety for Patients through Prescriber, Patient & Family Education

Disclosures. Objectives. The Opioid Epidemic: Improving Opioid Safety for Patients through Prescriber, Patient & Family Education The Opioid Epidemic: Improving Opioid Safety for Patients through Prescriber, Patient & Family Education Sharon Wrona, DNP, RN-BC, PNP, PMHS, AP-PMN Disclosures Sharon Wrona DNP, RN-BC, PNP, PMHS, AP-PMN

More information

The Opioid Epidemic: Improving Opioid Safety for Patients through Prescriber, Patient & Family Education

The Opioid Epidemic: Improving Opioid Safety for Patients through Prescriber, Patient & Family Education The Opioid Epidemic: Improving Opioid Safety for Patients through Prescriber, Patient & Family Education Sharon Wrona, DNP, RN-BC, PNP, PMHS, AP-PMN.... 1 Disclosures Sharon Wrona DNP, RN-BC, PNP, PMHS,

More information

2015 American Academy of Neurology

2015 American Academy of Neurology Prescribing Opioids for Pain in the Era of Changing Pain Management Guidelines Miroslav Misha Bačkonja, MD Department of Neurology University of Wisconsin, Madison Department of Neurology University of

More information

Financing Factors for Implementing Medication-Assisted Treatment

Financing Factors for Implementing Medication-Assisted Treatment Financing Factors for Implementing Medication-Assisted Treatment Jeremy Attermann, MSW, National Council for Behavioral Health Nick Szubiak, LCSW, National Council for Behavioral Health Brad DeCamp, MPA,

More information

2016 American Academy of Neurology

2016 American Academy of Neurology PCSS-O is a collaborative effort led by American Academy of Addiction Psychiatry (AAAP) in partnership with: Addiction Technology Transfer Center (ATTC), American Academy of Neurology (AAN), American Academy

More information

Motivational Interviewing in Managing Pain. Patricia Bruckenthal, PhD, APRN-BC, ANP, FAAN Stony Brook University School of Nursing

Motivational Interviewing in Managing Pain. Patricia Bruckenthal, PhD, APRN-BC, ANP, FAAN Stony Brook University School of Nursing Motivational Interviewing in Managing Pain Patricia Bruckenthal, PhD, APRN-BC, ANP, FAAN Stony Brook University School of Nursing 1 Educational Objectives At the conclusion of this activity participants

More information

Stress, Relaxation, and Mindful Breathing: A Primer. Kevin E. Vowles, Ph.D. University of New Mexico

Stress, Relaxation, and Mindful Breathing: A Primer. Kevin E. Vowles, Ph.D. University of New Mexico Stress, Relaxation, and Mindful Breathing: A Primer Kevin E. Vowles, Ph.D. University of New Mexico 1 Educational Objectives At the conclusion of this activity participants should be able to: State the

More information

Opioid Dependence 101 and Medication Assisted Treatment

Opioid Dependence 101 and Medication Assisted Treatment Opioid Dependence 101 and Medication Assisted Treatment Dr. Joji Suzuki Director of the Division of Addiction Psychiatry, Brigham & Women s Hospital Assistant Professor of Psychiatry, Harvard Medical School

More information

Objectives/Agenda 2/17/2015. Nancy Wiedemer, RN, MSN, CRNP Disclosures. Improving Pain Management in the Department of Veterans Affairs Part 2:

Objectives/Agenda 2/17/2015. Nancy Wiedemer, RN, MSN, CRNP Disclosures. Improving Pain Management in the Department of Veterans Affairs Part 2: Improving Pain Management in the Department of Veterans Affairs Part 2: Primary Care Based Support for Managing Chronic Opioid Therapy Nancy Wiedemer, RN,MSN,CRNP Pain Management Coordinator Philadelphia

More information

Pregnancy and Addiction

Pregnancy and Addiction Pregnancy and Addiction Carl Christensen, MD, PhD, D-FASAM Clinical Associate Professor, OB Gyn & Psychiatry Wayne State University School of Medicine November 16, 2016 1 Educational Objectives At the

More information

3/27/2019. Reducing Inpatient Opioid Consumption. Conflict of Interest. Educational Objectives

3/27/2019. Reducing Inpatient Opioid Consumption. Conflict of Interest. Educational Objectives Reducing Inpatient Opioid Consumption Creating a Therapeutic Foundation with Breakthrough Analgesia Based on Patient Function Chad Dieterichs, MD Peggy Lutz, FNP-BC, RN-BC March 27, 2019 1 Conflict of

More information

ASPMN Conference Baltimore, Maryland

ASPMN Conference Baltimore, Maryland ASPMN Conference Baltimore, Maryland Prescribing Controlled Substances Managing Risk and Optimizing Outcomes September 13, 2012 Tracey Fremd, NP Tracey Fremd Consulting, Inc. Most Common Uses for Controlled

More information

Managing Patients with Pain and Psychiatric Co-Morbidity. John A. Renner Jr., MD Division of Psychiatry Boston University School of Medicine

Managing Patients with Pain and Psychiatric Co-Morbidity. John A. Renner Jr., MD Division of Psychiatry Boston University School of Medicine Managing Patients with Pain and Psychiatric Co-Morbidity John A. Renner Jr., MD Division of Psychiatry Boston University School of Medicine 1 Educational Objectives At the conclusion of this activity participants

More information

Prescription Drug Abuse National Perspective

Prescription Drug Abuse National Perspective Prescription Drug Abuse National Perspective Timothy P. Condon, Ph.D. Science Policy Advisor Office of the Director White House Office of National Drug Control Policy Commonly Abused Prescription Drugs

More information

Main Results and Clinical Implications of the X:BOT Trial: XR-Naltrexone vs. Buprenorphine-Naloxone Film

Main Results and Clinical Implications of the X:BOT Trial: XR-Naltrexone vs. Buprenorphine-Naloxone Film Main Results and Clinical Implications of the X:BOT Trial: XR-Naltrexone vs. Buprenorphine-Naloxone Film July 31 st, 2018 Hosted by John A. Renner, Jr., MD, DLFAPA Professor of Psychiatry Boston University

More information

Using Treatment Agreements and Urine Drug Testing in Chronic Pain: Why, When, and How?

Using Treatment Agreements and Urine Drug Testing in Chronic Pain: Why, When, and How? Using Treatment Agreements and Urine Drug Testing in Chronic Pain: Why, When, and How? Joanna L. Starrels, MD, MS Albert Einstein College of Medicine Montefiore Medical Center July 29, 2015 1 Disclosures

More information

Opioid Use and Misuse: History, Trends, And The Oregon Opioid Initiative

Opioid Use and Misuse: History, Trends, And The Oregon Opioid Initiative Opioid Use and Misuse: History, Trends, And The Oregon Opioid Initiative John W. McIlveen, Ph.D., LMHC, State Opioid Treatment Authority, Oregon Health Authority, Addictions and Mental Health Division

More information

Pain Medication and Adolescents: Special Considerations

Pain Medication and Adolescents: Special Considerations Pain Medication and Adolescents: Special Considerations Patricia Cintra Franco Schram, MD Adolescent Substance Abuse Program Boston Children s Hospital Harvard Medical School 1 Educational Objectives At

More information

System Dynamics Modeling of Medical Use, Nonmedical Use and Diversion of Prescription Opioid Analgesics

System Dynamics Modeling of Medical Use, Nonmedical Use and Diversion of Prescription Opioid Analgesics System Dynamics Modeling of Medical Use, Nonmedical Use and Diversion of Prescription Opioid Analgesics Wayne Wakeland, Ph.D. Alexandra Nielsen, M.S. Teresa Schmidt, M.A. 30 th International System Dynamics

More information

Best Practices: Eight Principles for Safer Opioid Prescribing

Best Practices: Eight Principles for Safer Opioid Prescribing Best Practices: Eight Principles for Safer Opioid Prescribing Lynn R. Webster, MD Vice President of Scientific Affairs PRA International Salt Lake City, UT February 11, 2015 Dr Webster: Disclosures 12-Month

More information

Opioid Therapy For Pain: An Evidence Review

Opioid Therapy For Pain: An Evidence Review Opioid Therapy For Pain: An Evidence Review Roger Chou, MD Professor of Medicine Oregon Health & Science University Director, Pacific Northwest Evidence-based Practice Center 1 Educational Objectives At

More information

State Action to Prevent and

State Action to Prevent and State Action to Prevent and Treat Prescription Drug Abuse Paul Jarris, MD, MBA Executive Director Association of State and Territorial Health Officials Hearing from Each Other: State Reports NGA Policy

More information

Disclosures. Target Audience. A Focus on Local, Regional and Global Tools for Caring for Clients with Opioid Addictions

Disclosures. Target Audience. A Focus on Local, Regional and Global Tools for Caring for Clients with Opioid Addictions Disclosures A Focus on Local, Regional and Global Tools for Caring for Clients with Opioid Addictions Dana Murphy-Parker, MS, CRNP, PMHNP-BC, CARN-AP Carmel Clancy, PhD, RN, BSc (Hons), FPH The International

More information

The NIH Response to the Opioid Crisis from a Research Perspective

The NIH Response to the Opioid Crisis from a Research Perspective The NIH Response to the Opioid Crisis from a Research Perspective Wilson M. Compton, M.D., M.P.E., Deputy Director, National Institute on Drug Abuse Martha J. Somerman, DDS, PhD, Director, National Institute

More information

Adolescent Pain Management and NSAID Considerations

Adolescent Pain Management and NSAID Considerations American Dental Association PCSS-O Webinar June 7, 2018 Adolescent Pain Management and NSAID Considerations DMD, PhD, MPH Professor Pharmacology and Anesthesiology University of Pittsburgh School of Dental

More information

Docket No. FDA-2009-N-0143; Risk Evaluation and Mitigation Strategies for Certain Opioid Drugs

Docket No. FDA-2009-N-0143; Risk Evaluation and Mitigation Strategies for Certain Opioid Drugs June 30, 2009 Margaret Hamburg, MD Commissioner Food and Drug Administration U.S. Department of Health & Human Services 5630 Fishers Lane Rockville, MD 20852 Re: Docket No. FDA-2009-N-0143; Risk Evaluation

More information

Spirituality and Chronic Pain: Empirical Research Findings and Clinical Applications

Spirituality and Chronic Pain: Empirical Research Findings and Clinical Applications Spirituality and Chronic Pain: Empirical Research Findings and Clinical Applications Amy Wachholtz, PhD, MDiv, MS University of Colorado Denver Sept 20, 2016 1 Amy Wachholtz, Disclosures The author declares

More information

April 26, New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Board of Pharmacy Prescription Monitoring Program (PMP)

April 26, New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Nurse Practitioner Council New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) Peter Ryba, PharmD PMP Director

More information

Why pay for Continuing Education when you can get it for FREE!?

Why pay for Continuing Education when you can get it for FREE!? Why pay for Continuing Education when you can get it for FREE!? Special Projects Coordinator Arizona Center for Rural Health 9/15/17 This publication was supported by the Grant Number 1U17CE002717-01,

More information

Demystifying Buprenorphine Prescribing for Youth With Opioid Use Disorders. Providers Clinical Support System Opioid Therapies (PCSSO) CME 6/21/2017

Demystifying Buprenorphine Prescribing for Youth With Opioid Use Disorders. Providers Clinical Support System Opioid Therapies (PCSSO) CME 6/21/2017 Demystifying Buprenorphine Prescribing for Youth With Opioid Use Disorders Geetha A. Subramaniam MD, DFAACAP, DFAPA National Institute on Drug Abuse June 21, 2017 1 Providers Clinical Support System Opioid

More information

PRESCRIBING GUIDELINES

PRESCRIBING GUIDELINES Ohio Department of Health RESPONSE TO OHIO S PRESCRIPTION DRUG OVERDOSE EPIDEMIC: PRESCRIBING GUIDELINES MIPA CONFERENCE PREVENTING INJURY: FROM RESEARCH TO PRACTICE TO PEOPLE SEPTEMBER 30, 2013 Christy

More information

Prescription Drug Monitoring Programs and Other State-Level Strategies

Prescription Drug Monitoring Programs and Other State-Level Strategies Prescription Drug Monitoring Programs and Other State-Level Strategies Interventions to Reduce Opioid-Related Harms: Misuse, Abuse, Addiction, and Overdose Tamara M. Haegerich, PhD Acting Associate Director

More information

Arkansas Prescription Monitoring Program

Arkansas Prescription Monitoring Program Arkansas Prescription Monitoring Program FY 2017 Second Quarter Report October December 2016 Arkansas Prescription Monitoring Program Quarterly Report October December, Fiscal year 2017 Act 304 of 2011

More information

Treating Anxiety in the Substance Use Disordered Patient

Treating Anxiety in the Substance Use Disordered Patient Treating Anxiety in the Substance Use Disordered Patient August 26, 2015 Stephen A. Wyatt, D.O. Med. Dir., Addiction Medicine Carolina HealthCare System Charlotte, NC 1 No Financial Disclosures Target

More information

Prescription Opioid Overdose in Oregon: A public health perspective

Prescription Opioid Overdose in Oregon: A public health perspective Prescription Opioid Overdose in Oregon: A public health perspective Katrina Hedberg, MD, MPH Health Officer & State Epidemiologist Oregon Public Health Division Oregon Health Authority All-Cause Mortality,

More information

Report to the Legislature: Unsolicited Reporting Criteria Established and Process Review MN Prescription Monitoring Program

Report to the Legislature: Unsolicited Reporting Criteria Established and Process Review MN Prescription Monitoring Program This document is made available electronically by the Minnesota Legislative Reference Library as part of an ongoing digital archiving project. http://www.leg.state.mn.us/lrl/lrl.asp Minnesota Board of

More information

Opioid Overdose in Oregon Report to the Legislature

Opioid Overdose in Oregon Report to the Legislature SEPTEMBER 2018 Opioid Overdose in Oregon Report to the Legislature This report summarizes the burden of opioid overdose among Oregonians as required by ORS 432.141. It describes Oregon s progress in reducing

More information

Gabapentin diversion and misuse: Data from law enforcement and substance users

Gabapentin diversion and misuse: Data from law enforcement and substance users Gabapentin diversion and misuse: Data from law enforcement and substance users Mance E. Buttram, PhD NDEWS Presents Webinar 14 March 2018 Objectives 1. Brief overview of gabapentin literature 2. Present

More information

Hydrocodone Combination Analgesic Products Clinical Impact of a Schedule Change

Hydrocodone Combination Analgesic Products Clinical Impact of a Schedule Change Hydrocodone Combination Analgesic Products Clinical Impact of a Schedule Change Frederick A. Curro D.M.D., Ph.D. Director, PEARL Practice Based Research Network Director, Regulatory Affairs, Bluestone

More information

A Shifting Paradigm: From Biomedical to Biopsychosocial Interactions. Acknowledgement

A Shifting Paradigm: From Biomedical to Biopsychosocial Interactions. Acknowledgement A Shifting Paradigm: From Biomedical to Biopsychosocial Interactions Jeannie A. Sperry, PhD, LP, ABPP Co-chair, Division of Addictions, Transplant, and Pain, Department of Psychiatry and Psychology, Mayo

More information

CDC s Approach to Addressing the Opioid Overdose Epidemic

CDC s Approach to Addressing the Opioid Overdose Epidemic CDC s Approach to Addressing the Opioid Overdose Epidemic Sarah Bacon National Center for Injury Prevention and Control Division of Unintentional Injury Prevention June 23, 2016 500,000 drug overdose deaths

More information

Prescription Drug Abuse:

Prescription Drug Abuse: Prescription Drug Abuse: Regulatory Considerations Robert J. Burns Manager, Legislative and Regulatory Policy 202-789-5176 burnsr@ada.org Examining Prescription Drug Abuse Conference Call Prescription

More information

Improving Opioid Prescribing: The CDC Guideline for Prescribing Opioids for Chronic Pain, and Considerations for Dentistry

Improving Opioid Prescribing: The CDC Guideline for Prescribing Opioids for Chronic Pain, and Considerations for Dentistry National Center for Injury Prevention and Control Improving Opioid Prescribing: The CDC Guideline for Prescribing Opioids for Chronic Pain, and Considerations for Dentistry Debbie Dowell, MD, MPH American

More information

Managed Care Pushes for Safer Opioid Oversight

Managed Care Pushes for Safer Opioid Oversight Page 1 of 6 Clinical AUGUST 11, 2017 Managed Care Pushes for Safer Opioid Oversight High-risk pain Rx eyed Denver Health systems haven t escaped the nation s ongoing opioid crisis, as evidenced by surging

More information

PRESCRIPTION DRUG ABUSE: THE NATIONAL PERSPECTIVE

PRESCRIPTION DRUG ABUSE: THE NATIONAL PERSPECTIVE PRESCRIPTION DRUG ABUSE: THE NATIONAL PERSPECTIVE September 20, 2013 Association of State and Territorial Health Officials Annual Meeting R. Gil Kerlikowske Director of National Drug Control Policy National

More information

Beyond the Opioids: What matters most to people who visit emergency departments for pain-related complaints

Beyond the Opioids: What matters most to people who visit emergency departments for pain-related complaints Providers Clinical Support System PCSS-O March 21, 2018 Beyond the Opioids: What matters most to people who visit emergency departments for pain-related complaints Marian Wilson, PhD, MPH, RN-BC Assistant

More information

Opioid Safety in the Hospital and after Discharge

Opioid Safety in the Hospital and after Discharge Opioid Safety in the Hospital and after Discharge Melanie H. Simpson, PhD, RN-BC, OCN, CHPN, CPE Pain Team Coordinator, The University of Kansas Hospital Pres-Elect, American Society for Pain Management

More information

BJA Harold Rogers PDMP National Meeting on Data Driven Multi-Disciplinary Approaches to Reducing Rx Abuse

BJA Harold Rogers PDMP National Meeting on Data Driven Multi-Disciplinary Approaches to Reducing Rx Abuse SAMHSA Programs to Address Prescription Drug Misuse and Abuse Jinhee Lee, PharmD Division of Pharmacologic Therapies Center for Substance Abuse Treatment Substance Abuse and Mental Health Services Administration

More information

The Role of Dentists in Preventing Opioid Abuse Tufts Health Care Institute Program on Opioid Risk Management 12 th Summit Meeting March 11-12, 2010

The Role of Dentists in Preventing Opioid Abuse Tufts Health Care Institute Program on Opioid Risk Management 12 th Summit Meeting March 11-12, 2010 The Role of Dentists in Preventing Opioid Abuse Tufts Health Care Institute Program on Opioid Risk Management 12 th Summit Meeting March 11-12, 2010 EXECUTIVE SUMMARY It is well documented in multiple

More information

Presentation Objectives

Presentation Objectives Oregon s PDMP 101 Lisa Millet, MSH, Section Manager Injury and Violence Prevention Section Center for Prevention and Health Promotion Oregon Health Authority Eugene Oregon PDO Summit April 20, 2016 1 Presentation

More information

Meth and Opioid Abuse Prevention Efforts

Meth and Opioid Abuse Prevention Efforts Meth and Opioid Abuse Prevention Efforts Prescription Drugs/Opioids in South Dakota Departments of Health and Social Services Drug Abuse in South Dakota South Dakota ranked 2 nd lowest in the nation for

More information

Aetna s Initiative on the Opioid Epidemic

Aetna s Initiative on the Opioid Epidemic Aetna s Initiative on the Opioid Epidemic Christopher James D.O., M.P.H. Medical Director, BH- Mid-Atlantic Territory (JamesC1@aetna.com) July 23, 2017 HHS Data on Epidemic Every Day in the U.S. More than

More information

AVOIDING PHYSICIAN STRESS IN MEDICAL PAIN MANAGEMENT

AVOIDING PHYSICIAN STRESS IN MEDICAL PAIN MANAGEMENT AVOIDING PHYSICIAN STRESS IN MEDICAL PAIN MANAGEMENT OR HOW TO TREAT PATIENTS AND STAY OUT OF TROUBLE AT THE SAME TIME L AYN E E. SUBERA, D O CONTENTS 1. Perspectives on the opioid situation 2. Oklahoma

More information

AMERICA S OPIOID EPIDEMIC AND ITS EFFECT ON THE NATION S COMMERCIALLY-INSURED POPULATION PUBLISHED JUNE 29, 2017

AMERICA S OPIOID EPIDEMIC AND ITS EFFECT ON THE NATION S COMMERCIALLY-INSURED POPULATION PUBLISHED JUNE 29, 2017 AMERICA S OPIOID EPIDEMIC AND ITS EFFECT ON THE NATION S COMMERCIALLY-INSURED POPULATION PUBLISHED JUNE 29, 2017 America s Opioid Epidemic and Its Effect on the Nation s Commercially-Insured Population

More information

Public Policy Statement on the Regulation of Office-Based Opioid Treatment

Public Policy Statement on the Regulation of Office-Based Opioid Treatment Public Policy Statement on the Regulation of Office-Based Opioid Treatment Background Office-based opioid treatment (OBOT) commonly refers to outpatient treatment services provided outside of licensed

More information

Revised 9/30/2016. Primary Care Provider Pain Management Toolkit

Revised 9/30/2016. Primary Care Provider Pain Management Toolkit Revised 9/30/2016 Primary Care Provider Pain Management Toolkit TABLE OF CONTENTS 1. INTRODUCTION Page 1 2. NON-OPIOID SERVICES &TREATMENTS FOR CHRONIC PAIN Page 2 2.1 Medical Services Page 2 2.2 Behavioral

More information

FDA s Response to the Opioid Crisis and the FDA Safe Use Initiative

FDA s Response to the Opioid Crisis and the FDA Safe Use Initiative FDA s Response to the Opioid Crisis and the FDA Safe Use Initiative Scott K. Winiecki, MD Professional Affairs and Stakeholder Engagement Staff (PASES) Center For Drug Evaluation and Research (CDER) U.S.

More information

Massachusetts Responds to the Opioid Epidemic Using Data To Inform Policy and Programs. Monica Bharel, MD MPH Commissioner of Public Health

Massachusetts Responds to the Opioid Epidemic Using Data To Inform Policy and Programs. Monica Bharel, MD MPH Commissioner of Public Health Massachusetts Responds to the Opioid Epidemic Using Data To Inform Policy and Programs Monica Bharel, MD MPH Commissioner of Public Health Data For Massachusetts 2017 Q2 Quarterly Report and Chapter 55

More information

Virginia. Prescribing and Dispensing Profile. Research current through November 2015.

Virginia. Prescribing and Dispensing Profile. Research current through November 2015. Prescribing and Dispensing Profile Virginia Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points

More information

Florida PDMP User Survey Methodology

Florida PDMP User Survey Methodology Florida PDMP User Survey Methodology Florida Prescription Drug Monitoring Program (PDMP) conducted a survey in March 2013 to identify the barriers to PDMP utilization and opportunities for improvement.

More information

The CARA & Buprenorphine Prescribing for APNs & PAs

The CARA & Buprenorphine Prescribing for APNs & PAs The CARA & Buprenorphine Prescribing for APNs & PAs William J. Lorman, JD, PhD, MSN, PMHNP-BC, CARN-AP FIAAN Assistant Clinical Professor, Drexel University, Philadelphia, PA V. P. & Chief Clinical Officer,

More information

Arkansas Prescription Monitoring Program

Arkansas Prescription Monitoring Program Arkansas Prescription Monitoring Program FY 2016 Third Quarter Report January-March 2016 Arkansas Prescription Monitoring Program Quarterly Report January March, Fiscal year 2016 Act 304 of 2011 authorized

More information

Policy and Political Dynamics of the Opioid Addiction Crisis in the United States

Policy and Political Dynamics of the Opioid Addiction Crisis in the United States Policy and Political Dynamics of the Opioid Addiction Crisis in the United States Mark W. Parrino, M.P.A. July 21, 2018 15 th Annual Midwest Conference on Problem Gambling and Substance Abuse Hilton Kansas

More information

Approved Procedures for Prescribing and Monitoring Controlled Substances in South Carolina

Approved Procedures for Prescribing and Monitoring Controlled Substances in South Carolina Approved Procedures for Prescribing and Monitoring Controlled Substances in South Carolina Robert B. Hanlin, M.D., FAAFP Vice Chair, Medical Staff Affairs Greenville Health System Greenville, SC Disclosures

More information

CSS Perspective - Opioid Risk Management

CSS Perspective - Opioid Risk Management Tufts Health Care Institute Program on Opioid Risk Management Risk Evaluation and Mitigation Strategy for Prescription Opioids: An In-Depth Review of Fundamental Issues CSS Perspective - Opioid Risk Management

More information

SAFE OPIOID PRESCRIBING C.U.R.E.S. PROGRAM

SAFE OPIOID PRESCRIBING C.U.R.E.S. PROGRAM Sorin Buga, MD Associate Clinical Professor Department of Supportive Care City of Hope National Medical Center SAFE OPIOID PRESCRIBING C.U.R.E.S. PROGRAM Click to edit Master Presentation Date Disclosure

More information

OCCUPATIONAL AND PROFESSIONAL LICENSING MEDICINE AND SURGERY PRACTITIONERS MANAGEMENT OF PAIN AND OTHER CONDITIONS WITH CONTROLLED SUBSTANCES

OCCUPATIONAL AND PROFESSIONAL LICENSING MEDICINE AND SURGERY PRACTITIONERS MANAGEMENT OF PAIN AND OTHER CONDITIONS WITH CONTROLLED SUBSTANCES TITLE 16 CHAPTER 10 PART 14 OCCUPATIONAL AND PROFESSIONAL LICENSING MEDICINE AND SURGERY PRACTITIONERS MANAGEMENT OF PAIN AND OTHER CONDITIONS WITH CONTROLLED SUBSTANCES 16.10.14.1 ISSUING AGENCY: New

More information

Within the Scope of Practice/Role of _X APRN RN LPN CNA ADVISORY OPINION PAIN MANAGEMENT GUIDELIINES

Within the Scope of Practice/Role of _X APRN RN LPN CNA ADVISORY OPINION PAIN MANAGEMENT GUIDELIINES Wyoming State Board of Nursing 130 Hobbs Avenue, Suite B Cheyenne, WY 82002 Phone (307) 777-7601 Fax (307) 777-3519 E-Mail: wsbn-info-licensing@wyo.gov Home Page: https://nursing-online.state.wy.us/ OPINION:

More information

DEA: Combating the Supply

DEA: Combating the Supply Drug Enforcement Administration DEA: Combating the Supply 2nd Annual Opioid Abuse and Heroin Overdose Solutions Summit Cathy Gallagher Diversion Program Manager Detroit Division May 11, 2017 1 Prescription

More information

Mark W. Caverly, Chief Liaison and Policy Section

Mark W. Caverly, Chief Liaison and Policy Section DEA Issues: An Update Harold Rogers National Prescription Drug Monitoring Meeting Meeting September 24 25, 2009 Mark W. Caverly, Chief Liaison and Policy Section Prescription Drug Abuse Prescription Drug

More information

Medicare Advantage Outreach and Education Bulletin

Medicare Advantage Outreach and Education Bulletin Medicare Advantage Outreach and Education Bulletin Blue Cross and Blue Shield of Georgia Prescription Drug Monitoring Programs Prescription drug abuse and diversion are acute problems in the area of pain

More information

Report to the Legislature: Impact of the Minnesota Prescription Monitoring Program on Doctor Shopping

Report to the Legislature: Impact of the Minnesota Prescription Monitoring Program on Doctor Shopping Minnesota Board of Pharmacy Report to the Legislature: Impact of the Minnesota Prescription Monitoring Program on Doctor Shopping Prepared By: Dr. Katrina Howard, PMP Pharmacist Consultant October 31,

More information

Opioid Analgesics with Abuse- Deterrent Properties: Current Data and Future Opportunities

Opioid Analgesics with Abuse- Deterrent Properties: Current Data and Future Opportunities 1 National Academy of Medicine Session 4 Opioid Analgesics with Abuse- Deterrent Properties: Current Data and Future Opportunities Richard C. Dart, MD, PhD Director, Rocky Mountain Poison and Drug Center

More information

Category 4 Can we prove that ADF opioids really are?

Category 4 Can we prove that ADF opioids really are? Human Abuse Liability & Abuse-Deterrent Formulations Category 4 Can we prove that ADF opioids really are? March 7, 2016 Richard C. Dart, MD, PhD Director, Rocky Mountain Poison and Drug Center Executive

More information

Objectives 1/25/18. An Update on Controlled Substance Prescribing Laws & Rules for CNMs. Exclusionary Formulary Effective: May 17, 2017

Objectives 1/25/18. An Update on Controlled Substance Prescribing Laws & Rules for CNMs. Exclusionary Formulary Effective: May 17, 2017 1/25/18 An Update on Controlled Substance Prescribing Laws & Rules for CNMs Keeley Harding, DNP, APRN, CPNP-AC/PC February 4, 2018 2018 Ohio ACNM Forward Kalahari Resorts and Conference Center, Sandusky,

More information

Role of PMPs in Preventing Substance Abuse National Conference of State Legislatures December 6, 2006 San Antonio, Tx

Role of PMPs in Preventing Substance Abuse National Conference of State Legislatures December 6, 2006 San Antonio, Tx Role of PMPs in Preventing Substance Abuse National Conference of State Legislatures December 6, 2006 San Antonio, Tx Nick Reuter Division of Pharmacologic Therapy Substance Abuse and Mental Health Services

More information

Pennsylvania Prescription Drug Monitoring Program Trends,

Pennsylvania Prescription Drug Monitoring Program Trends, DEA Intelligence Report Brief DEA-PHL-DIR-006-17 Pennsylvania Prescription Drug Monitoring Program Trends, 2014-2015 December 2016 1 Executive Summary The abuse and diversion of pharmaceutical drugs, particularly

More information

Appendix F Federation of State Medical Boards

Appendix F Federation of State Medical Boards Appendix F Federation of State Medical Boards Model Policy Guidelines for Opioid Addiction Treatment in the Medical Office SECTION I: PREAMBLE The (name of board) recognizes that the prevalence of addiction

More information

Addressing the Opioid Epidemic: Prescribing Opioids for Non-Cancer Pain

Addressing the Opioid Epidemic: Prescribing Opioids for Non-Cancer Pain Addressing the Opioid Epidemic: Prescribing Opioids for Non-Cancer Pain Ajay D. Wasan, MD, MSc Professor of Anesthesiology and Psychiatry Vice Chair for Pain Medicine, Department of Anesthesiology University

More information

URINE DRUG TESTING FOR SUBSTANCE ABUSE TREATMENT AND CHRONIC PAIN MANAGEMENT

URINE DRUG TESTING FOR SUBSTANCE ABUSE TREATMENT AND CHRONIC PAIN MANAGEMENT Status Active Medical and Behavioral Health Policy Section: Laboratory Policy Number: VI-47 Effective Date: 07/21/2014 Blue Cross and Blue Shield of Minnesota medical policies do not imply that members

More information

Follow-up Q & A Webinar: The Role of Shame in Opioid Use Disorders

Follow-up Q & A Webinar: The Role of Shame in Opioid Use Disorders Follow-up Q & A Webinar: The Role of Shame in Opioid Use Disorders Ashley Braun-Gabelman, Ph.D. University Hospitals Case Medical Center Cleveland, Ohio 1 Ashley Braun-Gabelman, No Disclosures Disclosures

More information

Tennessee. Prescribing and Dispensing Profile. Research current through November 2015.

Tennessee. Prescribing and Dispensing Profile. Research current through November 2015. Prescribing and Dispensing Profile Tennessee Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points

More information

West Virginia. Prescribing and Dispensing Profile. Research current through November 2015.

West Virginia. Prescribing and Dispensing Profile. Research current through November 2015. Prescribing and Dispensing Profile West Virginia Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points

More information

Opioids: Current Status of the Crisis, Response, and Future Directions

Opioids: Current Status of the Crisis, Response, and Future Directions Opioids: Current Status of the Crisis, Response, and Future Directions Scott K. Winiecki, MD Professional Affairs and Stakeholder Engagement Staff (PASES) Center For Drug Evaluation and Research (CDER)

More information

Opioid Review and MAT Clinic CDC Guidelines

Opioid Review and MAT Clinic CDC Guidelines 1 Opioid Review and MAT Clinic CDC Guidelines January 10, 2018 Housekeeping Use chat feature to inform everyone who s at your clinic Click chat on Zoom option bar Chat Everyone the names of those who are

More information

Medication Assisted Treatment Georgia Statewide Conference September 12 th, 2016

Medication Assisted Treatment Georgia Statewide Conference September 12 th, 2016 Medication Assisted Treatment Georgia Statewide Conference September 12 th, 2016 Laurence M. Westreich, M.D. Associate Professor of Clinical Psychiatry Division of Alcoholism and Drug Abuse Department

More information

Medication and Behavioral Treatment of Substance Use Disorders

Medication and Behavioral Treatment of Substance Use Disorders Medication and Behavioral Treatment of Substance Use Disorders Brian Fuehrlein, MD, PhD Director, Psychiatric Emergency Room, VA Connecticut and Assistant Professor of Psychiatry, Yale University 1 Brian

More information

The Wisconsin Prescription Drug Monitoring Program. WI PDMP Timeline. PDMP Overview. What is a PDMP? PDMPs Across the Nation. Wisconsin.

The Wisconsin Prescription Drug Monitoring Program. WI PDMP Timeline. PDMP Overview. What is a PDMP? PDMPs Across the Nation. Wisconsin. The Wisconsin Prescription Drug Monitoring Program Wisconsin Nurses Association Jail Health Care Conference May 21, 2018 WI PDMP Timeline PDMP Overview January 2013 WI PDMP operational April 2017 WI epdmp

More information